| Roche Pharma (Schweiz) AG - Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung |
| 62510 | | 01 | | Perjeta 420 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L01FD02 | | | | 13.08.2012 | | |
|
| Composition |
| pertuzumabum 420 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 14 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Pertuzumabum | 420mg / 14ml |
| | BAG: Active Agent | Dose |
|---|
| Pertuzumabum | 420 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Histidine | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 2835.34 | 3100.00 | A | SL | Yes |
|
